Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content Volume 9 Issue 2 - February 2019

Oral pregabalin vs placebo for attenuation of hemodynamic response following direct laryngoscopy and endotracheal intubation

 

Shwetha Odeyar S1, Thirunavukkarasu Sivaraman2*

 

1Assistant Professor, Department of Anaesthesiology, BGS Global Institute of Medical Sciences, BGS Health and Education City,Bangalore-560060, INDIA.

2Senior Consultant, Sparsh super-speciality hospital, 4/1, Tumkur road, Yeshwanthpur,Bangalore-560022, INDIA.

Email: odeyarshwetha@gmail.com , dorephy@gmail.com

 

Abstract               Direct laryngoscopy and endotracheal intubation can be detrimental due to the associated hemodynamic response especially in patients with low cardiac reserve. This study aims at comparing the efficacy of oral pregabalin (150 mg) vs placebo in attenuating such a hemodynamic response. This study was designed as a prospective, double blind, randomized control trial set in the operating theatre of a tertiary care teaching hospital. Sixty patients of ASA PS -, , aged 18-60 years, both sex undergoing elective surgeries under general anaesthesia of 1-2 hours duration were divided into two groups. Group -oral placebo, Group -oral Pregabalin(150mg) sixty minutes before receiving general anaesthesia using standard technique. Results were analysed using paired and independent t test, ANOVA. P value ˂ 0.05 was considered statistically significant. Oral pregabalin has a greater attenuating effect on blood pressure than heart rate and effectively attenuates hemodynamic response associated with direct laryngoscopy and endotracheal intubation as compared to placebo.

Key Word: Oral Pregabalin; Placebo; hemodynamic response; intubation; laryngoscopy.

 

 

INTRODUCTION

Direct laryngoscopy and endotracheal intubation form the mainstay of general anaesthesia. This causes intense sympathetic discharge1,2,3 leading to transient, variable, unpredictable hemodynamic changes4 manifesting as tachycardia, hypertension, dysrhythmias. In susceptible individuals this manifests as myocardial insufficiency, pulmonary edema, left ventricular failure, cerebrovascular accidents5,6,7.These changes are at its peak 30-45 seconds following the procedure. Many methods have been developed to attenuate or prevent this hemodynamic response like deepening the plane of anaesthesia9, using lidocaine 8, using topical anesthesia10, omitting atropine as a premedicant11, premedicating with Nitroglycerin12, Betablockers13, calcium channel blockers14 and opioids15. The latest entrants to this group are gabapentin 16 and pregabalin17,18,19,20,21,22,23.Pregabalin is an anticonvulsant17 which is effective in neuropathic pain, incisional, inflammatory, formalin induced injury, anxiety and sleep modulation. It binds to alpha-2-delta 17 subunit of the presynaptic voltage gated calcium channels, reduces depolarization associated calcium influx and reduces the release of several neurotransmitters like glutamate, noradrenaline, serotonin, dopamine and substance P. It is rapidly absorbed orally with peak blood concentration being attained in 1 hour and 98% of absorbed drug excreted unchanged in urine. Due to this pharmacological profile, pregabalin can be a drug to attenuate hemodynamic response. The present study was undertaken to know the efficacy of oral pregabalin, 150mg18 in attenuating hemodynamic response to laryngoscopy and intubation by comparing it with a placebo in a double blind, prospective, randomized controlled study.

 

MATERIAL AND METHOD

After obtaining approval from institutional ethical committee and written informed consent from the patients, 60 ASA and patients of both sex in the age group of 18-60 years undergoing elective surgeries of 1-2hours duration under general anaesthesia were selected. By using simple random sampling, patients were allocated to two groups of 30 each. Group received oral placebo capsules and Group received oral pregabalin [150mg] capsules with sips of water 60 minutes before receiving standard general anaesthesia with endotracheal intubation.

 EXCLUSION CRITERIA

  • ASA-Physical status III and IV
  • Emergency Surgeries
  • Anticipated Difficult airway and morbid obesity
  • Pre existing cardiac disease, hypertension, asthma, severe renal or hepatic dysfunction.
  • History of antidepressant, anxiolytics,antipsychotic medications.
  • Pregnancy.
  • Elective surgeries of duration more than 2 hours.

Patients were premedicated with tab.Ranitidine 150mg, 12 hours and 90 minutes before and tab. Ondansetron 4mg, 90 minutes before shifting to Operating theatre. The basal heart rate and blood pressure were recorded before administering study drug 60 minutes before proposed procedure.In the OT, monitors – pulse oximeter, ECG, NIBP were connected, i. v access secured and crystalloid infusion started at 6-8ml/kg/hr. Patients received i.v glycopyrrolate 0.2mg and i. v midazolam 1mg. Preoxygenation done with 100% oxygen for three minutes. Inj Fentanyl 2mcg/kg i. v was given followed by Inj. Propofol 2mg/kg i.v, Inj Rocuronium 0.6mg/kg i.v . Mask ventilation done with 67% nitrous oxide, 33% oxygen for 90 seconds. Direct laryngoscopy done with no 3 or 4 Mcintosh blades and intubation with cuffed endotracheal tubes of 7.5 size in females and 8.5 size in males. Time taken for laryngoscopy and intubation was noted. The heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure were noted at 1,3,5,10,15 minutes after intubation and corresponding rate pressure product (mean heart rate x mean systolic blood pressure ) calculated. Both groups were maintained with 67% nitrous oxide, 33 % oxygen, Rocuronium 0.1mg/kg i. v boluses and isoflurane 0.4-0.8% with ventilator parameters on closed circuit adjusted to have end tidal carbon dioxide between 30-35mmHg. All patients were reversed with Inj. Neostigmine 0.05mg/kg i. v and Inj. Glycopyrrolate 0.01mg/kg i. v and extubated after complete recovery from neuromuscular blockade. Data analysis was done using Independent and paired sample t test, ANOVA and a p value ˂ 0.05 was considered statistically significant.

OBSERVATIONS AND RESULTS

On comparison, the two groups were similar in demographic profile and time taken for intubation , the predominant surgery in both groups were gynaecological procedures and pregabalin had a greater attenuation of blood pressure [p value ˂ 0.01] at 1,3,5 minutes than placebo as compared to heart rate [ p value= 0.4] at 1,3 minutes as shown in table 3

 

Table 1: showing demographic profile and duration of intubation

 

Group I ( Placebo)

Group II (Pregabalin)

Mean age [ years]

43.5± 7.23

45.2±5.84

Sex ratio [M:F]

10:20

10:20

Mean body weight [kg]

61.56 ± 11.27

59.13 ± 10.19

Mean Duration of intubation[seconds]

16.23 ± 2.215

16 ± 2.302

 

 

Table 2: showing type of surgeries

Type of surgery

Group I (placebo)

Number of patients

Group II (pregabalin)

Number of patients

General surgeries

8

9

Gynecological surgeries

17

18

Orthopedic surgeries

2

1

Ear Nose Throat surgeries

3

2

 

 

 

 

 

 

 

 

Table 3: showing hemodynamic variables

VARIABLE

GROUP

BASAL

PRE INDUCTION

1 MIN

3 MIN

5 MIN

10 MIN

15 MIN

Mean Heart rate

Placebo

Pregabalin

P value

80.76±15.89

84.13±10.15

0.34

87.26±16.19

85.3±10.33

0.58

94.96±18.41

92.13±8.3

0.4

94.5±16.75

91.6±11.24

0.42

93.93±15.74

87.8±10.02

0.08

89.23±14.9

81.76±9.9

0.02

87.4±12.18

80.56±7.64

0.01

Mean Systolic Blood Pressure

Placebo

Pregabalin

P value

131.76±16.78

132.16±10.96

0.91

132.53±21.04

131.43±14.39

0.81

124.83±26.5

109.09±15.0

0.00

 

116.93±23.7

101.8±8.17

0.00

110.23±15.63

99.86±11.47

0.00

 

108.93±14

94.6±14

0.01

112.1±17.1

102.5±12.1

0.02

Mean Diastolic Blood Pressure

Placebo

Pregabalin

P value

85.5±10.09

83.26±8.41

0.36

81.23±14.24

80.63±9.3

0.83

82.96±21.64

71.23±9.67

0.01

77.26±17.52

64.53±9.11

0.00

72.4±13.71

65.33±10.06

0.02

72.5±9.41

62.93±9.71

0.00

75.06±10.1

67.06±7.98

0.00

Mean Mean Arterial Pressure

Placebo

Pregabalin

P value

102.46±11.72

99.5±8.51

0.27

98.9±13.7

97.86±8.51

0.77

96.4±22.68

84.03±11.08

0.01

90.83±18.59

77.43±8.38

0.00

85.1±13.68

77.1±10.29

0.01

84.3±10.61

75.66±11.3

0.00

87.46±12.1

79.56±8.89

0.00

Mean Rate Pressure Product

Placebo

Pregabalin

P value

10584±2163

11006±1666

0.36

11283±2112

11183±1716

0.84

11726±2879

10072±1776

0.01

10910±2295

9370±1596

0.00

10247±1840

8828±1830

0.00

9648±1627

8213±1888

0.00

9789±2002

8315±1626

0.00


DISCUSSION

Direct laryngoscopy and endotracheal intubation leads to 10-20% rise in heart rate and 20-30% rise in blood pressure which can be detrimental in patients with hypertension, heart disease and cerebrovascular disease. Using a method to control heart rate and blood pressure can be life saving in such patients. Sundar AS et al20 showed that pregabalin more effectively attenuated the rise in blood pressure than heart rate in patients undergoing off pump CABG, much like our study. However, Gupta K et al18 compared oral pregabalin [150mg] and oral clonidine[200mcg] in elective laparoscopic cholecystectomy and found that both attenuated hemodynamic response with clonidine having increased incidence of intraoperative and postoperative bradycardia. Rastogi B et al22 compared two doses of pregabalin-75mg vs 150mg and found that 150mg attenuated hemodynamic response better.

Heart rate changes: Sundar AS et al20 had a lower rise in heart rate compared to this study probably due to use of preoperative beta blockers and higher doses of fentanyl [5mcg/kg], midazolam [50mcg/kg], Thiopentone [4mg/kg] compared to present study.

Systolic Blood pressure changes: The trend and magnitude of fall in systolic blood pressure was higher with pregabalin than placebo group.

Diastolic blood pressure changes: There is a greater fall in diastolic blood pressure in our study than Sundar AS et al 20.

Mean arterial pressure changes: Mean arterial pressure fell by 15-24 mmHg similar to study done by Sundar AS etal20. However, Gupta K21 showed a rise in mean arterial pressure at1,3,5 minutes. Rastogi B et al22 showed a fall lesser than this study probably due to use of butorphanol as premedicant against fentanyl.

 Rate pressure product changes: This is the product of systolic blood pressure and heart rate which correlates with myocardial oxygen consumption. Product of more than 20,000 is associated with myocardial ischemia. The increase in rate pressure product was higher in control group than pregabalin [p value ˂0.01].The other studies did not give information on rate pressure product. There were no side effects like nausea, vomiting in both groups. Three patients in pregabalin group had dizziness lasting 3-4 hours postoperatively which subsided by itself. Plasma catecholamines, the mediators of hemodynamic response were not measured and dose response effect of pregabalin was not studied. Drug interactions of pregabalin were not studied. The effect of pregabalin in patients with hypertension, diabetes mellitus needs to be studied as they are most susceptible for hemodynamic response.

 

CONCLUSION

Oral pregabalin (150 mg) given sixty minutes preoperatively successfully attenuates the hemodynamic response associated with direct laryngoscopy and endotracheal intubation. This effect is more prominent with the blood pressure component of the hemodynamic response than the heart rate component. However, the rise in heart rate is lower with pregabalin than placebo and the trend of the heart rate response is better and predictable with pregabalin.

 

REFERENCES

    • Burnstein C.L., Woloshin G, Newman N. Electrocardiographic studies during endotracheal intubation .Anesthesiology 1950; 11: 299-312
    •  Kayhan Z, Aldemir D, Metler H, Ogus E. Which is responsible for the haemodynamic response due to the laryngoscopy and endotracheal intubation? Catecholamines, vasopressin or angiotensin? .European Journal of Anaesthesiology 2005; 22: 780-5.
    • Morin AM, Gelbner G, Schwarz U, Kahl M, Adams HA, Hulf H, Eberhart LHJ. Factors influencing pre-operative stress responses in coronary artery bypass graft patients. BMC anaesthesiology 2004; 4(7).
    • Reid LC, Brace DE. Irritation of respiratory tract and its reflex effect upon heart .Surg Gynae obstet 1940; 70: 157-62.
    • Kovac AL. Controlling the haemodynamic response to laryngoscopy and endotracheal intubation. Journal of Clinical Anaesthesia 1996; 8: 63-79.
    • Prys-Roberts C, Green LT, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension II. Haemodynamic consequences of induction and endotracheal intubation.
    • Fox EJ, Sklar GS, Hill CH, Villanue Var, King BD. Complications related to the pressor response to endotracheal intubation. Anaesthesiology 1977; 47:524-5.
    • Stoelting R.K.Circulatory changes during direct laryngoscopy and intubation influence of duration of laryngoscopy with or without prior lidocaine .Anesthesiology 1977;47:381-4
    •  King B.D., Harris L.C., Greifenstein. F.E., Elder J.D., Dripps R.D. Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed during general anaesthesia. Anaesthesiology 1951Sept; 556-66.
    • Wycoff C.C. Endotracheal intubation: effects on blood pressure and pulse rate. Anaesthesiology 1960 Mar-Apr; 153-58.
    • Fassoulaki A, Kaniaris P. Does atropine premedication affect cardiovascular response to laryngoscopy and intubation?. British Journal of anaesthesia 1987; 59: 295-9.
    • Fassoulaki. A. Kaniaris P. Intranasal administration of Nitroglycerine attenuates the pressor response to laryngoscopy and intubation of trachea.British journal of anaesthesia 1983; 55: 49-52.
    • Vucevic M, Purdy G.M., Ellis F.R. Esmolol hydrochloride for managing hemodynamic response to laryngoscopy and intubation .British journal of anaesthesia 1992;68:529-30
    • Mikawa K., Ilegaki. J, Malkawa. N. Goto R, Kaestsu. H, Obaral. The effect of diltiazem on hemodynamic response to laryngscopyand intubation.Anaesthesia 1990;45: 289-93.
    • Miller Dr ,Martineau R.J, Obrien H, Hull K.A, Oliveras, L.Hindmarsh. T., Greenway D. Effects of alfenatanil on the hemodynamic and catecholamine response to tracheal intubation. Anaesthesia Analgesia 1993; 76: 1040-6.
    • Fassoulaki. A.Melemeni, Paraskeva A., Petropoulos. G .Gabapentin attenuates the pressor response to direct laryngoscopy and tracheal intubation. British journal of anaesthesia 2006; 96(6): 769-73.
    • Gajraj M.N., Pregabalin . Its pharmacology and use in Pain management. Anesthesia and Analgesia 2007 dec; 105 :1805-15.
    • Gupta K, Sharma. D, Gupta P.K. Oral premedication with pregabalin or clonidine for emodynamic stability during laryngoscopy and laparascopic cholecystectomy -A comparative evaluation. Saudi Journal of Anaesthesia 2011; 5: 179-84.
    • Gulay E, Betul.K ,Oya H., Unsal.B., Gurray D, Zafer.C. Pregabalin blunts cardiovascular response to laryngoscopy and tracheal intubation .Journal of anaesthesiology and reanimation 2009; Volume 7(2).(abstract from website) anestezi.turkiyeklinikleri.com/abstract tr55466.html
    • Sundar AS, Kodali R , Sulaiman S, Ravullapalli H,Karthekayan R, Vakamudi M. The effects of preemptive pregabalin on attenuation of stress response to endotracheal intubation and pioid sparing effect in patients undergoing off pump coronary artery bypass grafting. Ann Card Anaesth 2012; 15: 18-25.
    • Gupta K ,Bansal P,Gupta PK , Singh YP. Pregabalin premedication – A new treatment option for hemodynamic stability during general anesthesia: A prospective study. Anesth Essays Res 2011; 5: 57-62.
    • Rastogi B , Gupta K , Gupta PK , Agarwal S , Jain M , Chauhan H . Oral pregabalin premedication for attenuation of hemodynamic response of airway instrumentation during general anaesthesia: A dose response study. Indian J Anaesth 2012; 56:49 – 54.
    • Waikar C, Singh J, Gupta D, Agrawal A. Comparative Study of Oral Gabapentin, Pregabalin, and Clonidine as Premedication for Anxiolysis, Sedation, and Attenuation of Pressor Response to Endotracheal Intubation. Anesth Essays Res. 2017; 11(3):558-560.